Sun, Wockhardt recall drugs from US market

Hyderabad: Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of drugs from the US market due to different reasons.

Representational image. AFP

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-¬release Tablets USP (SR), 200 mg, 60-count bottle, from the US market for “failed dissolution specification”, while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg from the same market for “CGMP violations”.

According to a notification issued by the US Food and Drug Administration, Sun Pharma’s recall was initiated last month under Class-III classification which was as ‘a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences’

Sun, Wockhardt recall drugs from US market

read at……http://www.firstpost.com/business/sun-wockhardt-recall-drugs-from-us-market-2413690.html